These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 16272650

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of cyclase activating (CAP) and cyclase inhibiting (CIP) parathormone fractions in the assessment of bone metabolism disturbances in women with hyperprolactinemia of various origin.
    Zadrozna-Sliwka B, Bolanowski M, Jawiarczyk A, Kaluzny M, Syrycka J.
    Neuro Endocrinol Lett; 2008 Feb; 29(1):178-84. PubMed ID: 18283239
    [Abstract] [Full Text] [Related]

  • 25. Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients.
    Inaba M, Okuno S, Chou H, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y.
    Biomed Pharmacother; 2006 Feb; 60(2):62-5. PubMed ID: 16460905
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients.
    Shidara K, Inaba M, Okuno S, Imanishi Y, Yamakawa T, Ishimura E, Kumeda Y, Nishizawa Y.
    Biomed Pharmacother; 2007 Feb; 61(2-3):142-7. PubMed ID: 17270383
    [Abstract] [Full Text] [Related]

  • 28. Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.
    López Gavilanes E, González Parra E, de la Piedra C, Caramelo C, Rapado A.
    Miner Electrolyte Metab; 1994 Feb; 20(5):259-64. PubMed ID: 7700213
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
    Broulík P, Hrubý M.
    Cas Lek Cesk; 1993 Nov 22; 132(22):681-3. PubMed ID: 8293434
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
    Albalate M, de la Piedra C, Fernández C, Lefort M, Santana H, Hernando P, Hernández J, Caramelo C.
    Nephrol Dial Transplant; 2006 Jun 22; 21(6):1626-32. PubMed ID: 16490746
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
    Takahashi N, Kojima T, Ogawa H, Ishiguro N.
    Nephrology (Carlton); 2007 Dec 22; 12(6):539-45. PubMed ID: 17995578
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.